Iloprost
Back to searchMolecule Structure
Scientific Name
Iloprost
Description of the Drug
Iloprost is a synthetic prostacyclin analog indicated to treat pulmonary arterial hypertension (PAH).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01088
http://www.drugbank.ca/drugs/DB01088
Brand Name(s)
Ventavis
Company Owner(s)
Actelion Pharmaceuticals Us Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Prostanoid IP receptor | SINGLE PROTEIN | AGONIST | CHEMBL1995 |
Clinical Trial(s)
Unichem Links
| Atlas | iloprost | |
| SureChEMBL | SCHEMBL6083382 | |
| DrugBank | DB01088 | |
| PubChem: Thomson Pharma | 14876806 | 14925954 |
| PubChem | 5311181 | |
| LINCS | LSM-43147 | |
| BindingDB | 23954 | |
| DrugCentral | 1422 | |
| ChemicalBook | CB0775438 | CB3775439 |
| GSRS | d2b124f0-0c5a-4f60-bf58-d7a0a91e34f2 | |
| rxnorm | ILOPROST | VENTAVIS |
| PubChem: Drugs of the Future | 12013823 | |
| ChEBI | 63916 |
